The firm served as lead counsel for Biotec Pharmacon, ASA, a Norwegian pharmaceutical company, in patent infringement litigation initiated by patent owner Biothera, a Minnesota corporation, in the District of Minnesota in Minneapolis. The 14 patents involved in the litigation relate to, among other things, beta glucan compositions for immunotherapy. The District Court granted summary judgment of non-infringement as to 12 of the 14 patents, and the case subsequently settled. Biopolymer Eng'g, Inc. v. Immunocorp, No. 05-536 (D. Minn. filed Mar. 14, 2005).

Experience Center

Match our Experience to Your Needs

Experience Highlights

Insurance coverage litigation for a government contractor regarding losses resulting from Hurricane Katrina
The firm represented a government contractor in litigation, successfully settled, regarding coverage for catastrophic property damage and business more
The Coca Cola Co. v. PepsiCo Inc., et al.
Represented Pepsi-Cola Co. and PepsiCo in a patent infringement suit brought by Coca-Cola in the Northern District of Georgia involving bag-in-box more
Federal grand jury investigation of a former executive
Represented a former executive of an oil field services company being investigated by the Department of Justice, Antitrust Division, in a federal more
Carbon sequestration programs and carbon credits for major wood products manufacturer
Represented major wood products manufacturing client with its ongoing efforts to identify and capitalize on state carbon sequestration programs more